Angiodynamics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 8, 2026, 7:17 a.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedAngioDynamics Q1 FY2027 net sales rise 6.9% to $80.9 million; Med Tech up 13.2%, FY2027 guidance reiterated, CEO transition to Eric Honroth
8-KOct. 8, 2026, 7:16 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Departure/appointment of directors or officers · Financial statements and exhibits
AI summary, unreviewedAngioDynamics Names Eric Honroth CEO Effective November 2, 2026, Succeeding James Clemmer After Ten Years